The Chinese health industry has gone from a traditional mode to a new one, since the medical network sounded the new law in 2008.
In 2017, coincided with the heap will usher in the first ten years, congress to "build blueprint, focusing on the demand of the market awakening" as the theme, combed the industrial structure in the past ten years, to discuss a new decade industry development.
The five changes in the industry decade
Through the decade development of the industry, China kang information has summarized five important industrial changes.
First, the health industry has achieved rapid growth with a policy based dividend, but the growth rate has returned rationally.The market status of retail industry is rapidly rising, becoming a mainstream force in the industry., according to information of kang President Wu Han from 17th 2007 clear health guidelines, to the new reform in earnest, industry entered a new phase of development, although experienced during the global financial crisis, but the kang CMH monitoring data show that the industry's defensive we still get the compound growth rate 15%, terminal market scale growth from the beginning of 483.5 billion to 1.4909 trillion last year, during both dividend policy mainly driven by high growth of 20%, there are 7% - 7% of the rational return at the end of the semester.
Second, the Internet and big data are permeating the health industry.With the advantage of the Internet and big data technology technology giants began to enter the health field, and the traditional industry service providers take consumers and make the trajectory of the future industry more uncertainty.
Thirdly, the barbaric growth of industry has become unsustainable, and compliance, innovation and adaptation to the new ecology will be the way to survive in the future.Kang information analysis, points out that in ten years of the new medical reform for the industry experienced a roller coaster, and in the early stage of the basic input stage, a booming market, won more than 17% of the drug for five consecutive years to grow, even reach 20% growth in 2010.However, as the reform has entered into the phase of cost control lift efficiency, especially in health care into the deep waters, three-dimensional New Deal to make industry "cold winter", since 2015 years growth has been going down to single digits.China's pharmaceutical enterprises will face greater challenges after China joins ICH and the implementation of DRG.
Fourth, the drug structure changes, the marginal expansion of the industry.Ariations on the one hand, and population structure change, changed the medication structure in our country, the rapid growth of antineoplastic drugs and become the focus of firms, cardiovascular medicine total scale instead of anti-infective medicine as the first place, regain: children's category growth, county town of medical level, the gap between urban and rural areas;, on the other hand, consumers' health demand increasingly diversification, personalization, pure "d" and "medicine" is difficult to fully meet the requirements, health industry instead of the pharmaceutical industry to become the industry more accurate summary, marginal industry expansion.Moreover, as the information becomes more transparent and the development of technology, consumer sovereignty consciousness continues to increase.
Fifth, capital has become a powerful thrust of the changing industrial landscape.Along with our country multi-level capital market system is built, and the favour of capital on health industry, capital is used by a large number of tools in the industry, optimize the distribution of industry resources, improve industrial concentration, promote the industrial innovation, industrial structure change.
Five trends in future industries
If the traditional model has come to an end, how will the future industry find its way and build an industrial blueprint?That is what will be at the heart of the 2017 heap.
Key kang in information analysis, with the new medical reform policy into the assessment of ground change of industrial structure, capital strength enhancement, the comprehensive penetration of technology innovation, and speed boost cross-border fusion, 2017 is the watershed of industrial development, the future will present five trends:
[trend 1] the differentiation of industrial dominance and the gradual formation of "dual market" structure
With the change of the medical insurance payment methods, the growth of the commercial insurance power, doctors more practice led by voice enhanced, higher proportion of the middle class, information transparency, and fu can from technology, industry control will differentiation to consumers, consumers face - commercial insurance institutions and related health services will be more of a say and become a dominant force.This force will create a "binary market" structure: a basic market dominated by government, relatively stable structure and broad coverage.An active consumer market which is represented by commercial insurance and health management institutions to meet the diversified needs of high and middle income people.The analysis points out that different market competition modes are very different, and pharmaceutical enterprises need to combine their own characteristics to be well positioned.
[trend 2] healthy industry growth pole shift
The pharmaceutical market has been an important growth pole in the past due to the relatively monotonous demand and the use of medicine and medicine.Along with the health needs of diversification, medicine for the medical system reform, the change of the payment, drug market will slow growth in a long time to maintain the level, the lack of core competitiveness of enterprises will be excluded from the market quickly;The health and health services market will be a major contributor to the growth of the health industry and industry growth will shift from product to service.
[trend 3] industrial service supply chain structure changes
With the development of technology, the change of demand patterns and the evolution of social organization form, a continue to shorten the distance with consumer, specialized division of labor and systematic service of combining the supply chain structure will be formed.This puts forward higher requirements for brand construction and accurate positioning of enterprises or various service agencies;At the same time, the market also has a strong demand for service providers with professional linking ability, so as to better coordinate the supply resources of various professional institutions and systematically meet the health needs of consumers.
[trend 4] data application ability will become the basic ability of enterprise development
The data will be more widely used in the health industry, including business decisions, medical services, drug development and production, circulation and use, payment, etc.About data, meanwhile, has an idea needs to change: data is energy, but kang information that must be emphasized is, data is not oil, it is the solar energy, not exclusive, only applied value.The trend of data sharing and information isolation is an inevitable trend.
Trend 5: the wide application of Internet technology and artificial intelligence
Internet is widely used in the medical process, artificial intelligence in the field of medical and health management to create value, will be fully represented by the doctor's liberation the productivity of health service providers, to satisfy more requirements, at the same time, with increased efficiency also become the impetus to expand the market.
Growth forecast for terminal use in 2017:5.8%
In 2016, China's drug terminal market (excluding medicinal materials) totaled 14.909 billion yuan, an increase of 8.2 percent year-on-year, according to the China kang CMH data.The forecast for 2017 will fall to 5.8 per cent.Zero rate expanded, health care, drug bid price, the centralized purchasing negotiation, health various comprehensive reform measures such as price negotiations is the main factors influencing drug sales continue to high growth.
PaUp [1] [2] PaDn
|
